Inflammatory responses mediated by the transcription factor nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) play key roles in immunity, autoimmune diseases, and cancer. NF-κB is directly regulated through protein-protein interactions, including those with IκB and 14-3-3 proteins. These two important regulatory proteins have been reported to interact with each other, although little is known about this interaction. We analyzed the inhibitor of nuclear factor kappa B α (IκBα)/14-3-3σ interaction via a peptide/protein-based approach. Structural data were acquired via X-ray crystallography, while binding affinities were measured with fluorescence polarization assays and time-resolved tryptophan fluorescence. A high-resolution crystal structure (1.13 Å) of the uncommon 14-3-3 interaction motif of IκBα (IκBαpS63) in a complex with 14-3-3σ was evaluated. This motif harbors a tryptophan that makes this crystal structure the first one with such a residue visible in the electron density at that position. We used this tryptophan to determine the binding affinity of the unlabeled IκBα peptide to 14-3-3 via tryptophan fluorescence decay measurements.

Department of Biomedical Engineering Laboratory of Chemical Biology and Institute for Complex Molecular Systems Eindhoven University of Technology P O Box 513 5600 MB Eindhoven The Netherlands

Department of Organic Chemistry University of Duisburg Essen 45117 Essen Germany

Department of Physical and Macromolecular Chemistry Faculty of Science Charles University Prague 12843 Czech Republic

Institute of Physics Faculty of Mathematics and Physics Charles University Prague 12116 Czech Republic

Zobrazit více v PubMed

Hayden M. S.; Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26, 203–234. 10.1101/gad.183434.111. PubMed DOI PMC

Viatour P.; Merville M.-P.; Bours V.; Chariot A. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 2005, 30, 43–52. 10.1016/j.tibs.2004.11.009. PubMed DOI

Ghosh S.; May M. J.; Kopp E. B. NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses. Annu. Rev. Immunol. 1998, 16, 225–260. 10.1146/annurev.immunol.16.1.225. PubMed DOI

Baldwin A. S. Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14, 649–683. 10.1146/annurev.immunol.14.1.649. PubMed DOI

Gupta S. C.; Sundaram C.; Reuter S.; Aggarwal B. B. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim. Biophys. Acta, Gene Regul. Mech. 2010, 1799, 775–787. 10.1016/j.bbagrm.2010.05.004. PubMed DOI PMC

Mulero M. C.; Bigas A.; Espinosa L. IκBα beyond the NF-kB dogma. Oncotarget 2013, 4, 1550–1551. 10.18632/oncotarget.1325. PubMed DOI PMC

DiDonato J.; Mercurio F.; Roette C.; Wu-Li J.; Suyang H.; Ghosh S.; Karin M. Mapping of the Inducible IκB Phosphorylation Sites That Signal Its Ubiquitination and Degradation. Mol. Cell. Biol. 1996, 16, 1295–1304. 10.1128/MCB.16.4.1295. PubMed DOI PMC

Gonen H.; Bercovich B.; Orian A.; Carrano A.; Takizawa C.; Yamanaka K.; Pagano M.; Iwai K.; Ciechanover A. Identification of the Ubiquitin Carrier Proteins, E2s, Involved in Signal-induced Conjugation and Subsequent Degradation of IκBα. J. Biol. Chem. 1999, 274, 14823–14830. 10.1074/jbc.274.21.14823. PubMed DOI

Simeonidis S.; Liang S.; Chen G.; Thanos D. Cloning and functional characterization of mouse IκBε. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 14372–14377. 10.1073/pnas.94.26.14372. PubMed DOI PMC

Malek S.; Chen Y.; Huxford T.; Ghosh G. IκBβ, but not IκBα, functions as a classical cytoplasmic inhibitor of NF-κB dimers by masking both NF-κB nuclear localization sequences in resting cells. J. Biol. Chem. 2001, 267, 45225–45235. 10.1074/jbc.M105865200. PubMed DOI

Tran K.; Merika M.; Thanos D. Distinct Functional Properties of IκBα and IκBε. Mol. Cell. Biol. 1997, 17, 5386–5399. 10.1128/MCB.17.9.5386. PubMed DOI PMC

Aguilera C.; Fernández-Majada V.; Inglés-Esteve J.; Rodilla V.; Bigas A.; Espinosa L. Efficient nuclear export of p65-IκBα complexes requires 14-3-3 proteins. J. Cell Sci. 2016, 129, 2472.10.1242/jcs.192641. PubMed DOI

Johnson C.; Tinti M.; Wood N. T.; Campbell D. G.; Toth R.; Dubois F.; Geraghty K. M.; Wong B. H. C.; Brown L. J.; Tyler J.; Gernez A.; Chen S.; Synowsky S.; MacKintosh C. Visualization and Biochemical Analyses of the Emerging Mammalian 14-3-3-Phosphoproteome. Mol. Cell. Proteomics 2011, 10, M110.00575110.1074/mcp.M110.005751. PubMed DOI PMC

Fu H.; Subramanian R. R.; Masters S. C. 14-3-3 Proteins: Structure, Function, and Regulation. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 617–647. 10.1146/annurev.pharmtox.40.1.617. PubMed DOI

Aitken A. 14-3-3 proteins: A historic overview. Semin. Cancer Biol. 2006, 16, 162–172. 10.1016/j.semcancer.2006.03.005. PubMed DOI

Yaffe M. B.; Rittinger K.; Volinia S.; Caron P. R.; Aitken A.; Leffers H.; Gamblin S. J.; Smerdon S. J.; Cantley L. C. The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity. Cell 1997, 91, 961–971. 10.1016/S0092-8674(00)80487-0. PubMed DOI

Palmer D.; Jimmo S. L.; Raymond D. R.; Wilson L. S.; Carter R. L.; Maurice D. H. Protein Kinase A Phosphorylation of Human Phosphodiesterase 3B Promotes 14-3-3 Protein Binding and Inhibits Phosphatase-catalyzed Inactivation. J. Biol. Chem. 2007, 282, 9411–9419. 10.1074/jbc.M606936200. PubMed DOI

Sun L.; Stoecklin G.; Way S. V.; Hinkovska-Galcheva V.; Guo R.-F.; Anderson P.; Shanley T. P. Tristetraprolin (TTP)-14-3-3 Complex Formation Protects TTP from Dephosphorylation by Protein Phosphatase 2a and Stabilizes Tumor Necrosis Factor-α mRNA. J. Biol. Chem. 2007, 282, 3766–3777. 10.1074/jbc.M607347200. PubMed DOI

Zhang J.; Chen F.; Li W.; Xiong Q.; Yang M.; Zheng P.; Li C.; Pei J.; Ge F. 14-3-3ζ Interacts with Stat3 and Regulates Its Constitutive Activation in Multiple Myeloma Cells. PLoS One 2012, 7, e2955410.1371/journal.pone.0029554. PubMed DOI PMC

Obsilova V.; Nedbalkova E.; Silhan J.; Boura E.; Herman P.; Vecer J.; Sulc M.; Teisinger J.; Dyda F.; Obsil T. The 14-3-3 Protein Affects the Conformation of the Regulatory Domain of Human Tyrosine Hydroxylase. Biochemistry 2008, 47, 1768–1777. 10.1021/bi7019468. PubMed DOI

Herman P.; Lee J. C. Functional Energetic Landscape in the Allosteric Regulation of Muscle Pyruvate Kinase. 2. Fluorescence Study. Biochemistry 2009, 48, 9456–9465. 10.1021/bi900280u. PubMed DOI PMC

Herman P.; Vecer J.; Scognamiglio V.; Staiano M.; Rossi M.; D’Auria S. A Recombinant Glutamine-Binding Protein from Escherichia coli: Effect of Ligand-Binding on Protein Conformational Dynamics. Biotechnol. Prog. 2004, 20, 1847–1854. 10.1021/bp049956u. PubMed DOI

Eftink M. R.Intrinsic Fluorescence of Proteins. In Topics in Fluorescence Spectroscopy; Lakowicz J. R., Ed.; Springer: US, Boston, MA, 2000; Vol. 6, pp 1–15.

Principles of Fluorescence Spectroscopy; Lakowicz J. R., Ed.; Springer: US, Boston, MA, 2006.

Gryczynski I.; Wiczk W.; Johnson M. L.; Lakowicz J. R. Lifetime distributions and anisotropy decays of indole fluorescence in cyclohexane/ethanol mixtures by frequency-domain fluorometry. Biophys. Chem. 1988, 32, 173–185. 10.1016/0301-4622(88)87005-4. PubMed DOI

Stevers L. M.; de Vries R. M. J. M.; Doveston R.; Milroy L.-G.; Brunsveld L.; Ottmann C. Structural interface between LRRK2 and 14-3-3 protein. Biochem. J. 2017, 7, 1273–1287. 10.1042/BCJ20161078. PubMed DOI

Stevers L. M.; Lam C. V.; Leysen S. F. R.; Meijer F. A.; van Scheppingen D. S.; de Vries R. M. J. M.; Carlile G. W.; Milroy L. G.; Thomas D. Y.; Brunsveld L.; Ottmann C. Characterization and small-molecule stabilization of the multisite tandem binding between 14-3-3 and the R domain of CFTR. Proc. Natl. Acad. Sci. U.S.A. 2016, 113, E1152–E1161. 10.1073/pnas.1516631113. PubMed DOI PMC

Kalabova D.; Smidova A.; Petrvalska O.; Alblova M.; Kosek D.; Man P.; Obsil T.; Obsilova V. Human procaspase-2 phosphorylation at both S139 and S164 is required for 14-3-3 binding. Biochem. Biophys. Res. Commun. 2017, 493, 940–945. 10.1016/j.bbrc.2017.09.116. PubMed DOI

Madeira F.; Tinti M.; Murugesan G.; Berrett E.; Stafford M.; Toth R.; Cole C.; MacKintosh C.; Barton G. J. 14-3-3-Pred: improved methods to predict 14-3-3-binding phosphopeptides. Bioinformatics 2015, 31, 2276–2283. 10.1093/bioinformatics/btv133. PubMed DOI PMC

Alblova M.; Smidova A.; Docekal V.; Vesely J.; Herman P.; Obsilova V.; Obsil T. Molecular basis of the 14-3-3 protein-dependent activation of yeast neutral trehalase Nth1. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, E9811–E9820. 10.1073/pnas.1714491114. PubMed DOI PMC

Joo Y.; Schumacher B.; Landrieu I.; Bartel M.; Smet-Nocca C.; Jang A.; Choi H. S.; Jeon N. L.; Chang K.-A.; Kim H.-S.; Ottmann C.; Suh Y.-H. Involvement of 14-3-3 in tubulin instability and impaired axon development is mediated by Tau. FASEB J. 2015, 29, 4133–4144. 10.1096/fj.14-265009. PubMed DOI

Kacirova M.; Novacek J.; Man P.; Obsilova V.; Obsil T. Structural Basis for the 14-3-3 Protein-Dependent Inhibition of Phosducin Function. Biophys. J. 2017, 112, 1339–1349. 10.1016/j.bpj.2017.02.036. PubMed DOI PMC

Psenakova K.; Petrvalska O.; Kylarova S.; Lentini Santo D.; Kalabova D.; Herman P.; Obsilova V.; Obsil T. 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2). Biochim. Biophys. Acta, Gen. Subj. 2018, 1862, 1612–1625. 10.1016/j.bbagen.2018.04.006. PubMed DOI

Park E.; Rawson S.; Li K.; Kim B.-W.; Ficarro S. B.; Pino G. G.-D.; Sharif H.; Marto J. A.; Jeon H.; Eck M. J. Architecture of autoinhibited and active BRAF–MEK1–14-3-3 complexes. Nature 2019, 575, 545–550. 10.1038/s41586-019-1660-y. PubMed DOI PMC

Sluchanko N. N.; Beelen S.; Kulikova A. A.; Weeks S. D.; Antson A. A.; Gusev N. B.; Strelkov S. V. Structural Basis for the Interaction of a Human Small Heat Shock Protein with the 14-3-3 Universal Signaling Regulator. Structure 2017, 25, 305–316. 10.1016/j.str.2016.12.005. PubMed DOI PMC

Tugaeva K. V.; Kalacheva D. I.; Cooley R. B.; Strelkov S. V.; Sluchanko N. N. Concatenation of 14-3-3 with partner phosphoproteins as a tool to study their interaction. Sci. Rep. 2019, 9, 1500710.1038/s41598-019-50941-3. PubMed DOI PMC

Vincenz C.; Dixit V. M. 14-3-3 Proteins Associate with A20 in an Isoform-specific Manner and Function Both as Chaperone and Adapter Molecules. J. Biol. Chem. 1996, 271, 20029–20034. 10.1074/jbc.271.33.20029. PubMed DOI

Agarwal-Mawal A.; Qureshi H. Y.; Cafferty P. W.; Yuan Z.; Han D.; Lin R.; Paudel H. K. 14-3-3 Connects Glycogen Synthase Kinase-3β to Tau within a Brain Microtubule-associated Tau Phosphorylation Complex. J. Biol. Chem. 2003, 278, 12722–12728. 10.1074/jbc.M211491200. PubMed DOI

Saline M.; Badertscher L.; Wolter M.; Lau R.; Gunnarsson A.; Jacso T.; Norris T.; Ottmann C.; Snijder A. AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins. J. Biol. Chem. 2019, 294, 13106–13116. 10.1074/jbc.RA119.008649. PubMed DOI PMC

Centorrino F.; Ballone A.; Wolter M.; Ottmann C. Biophysical and structural insight into the USP8/14-3-3 interaction. FEBS Lett. 2018, 592, 1211–1220. 10.1002/1873-3468.13017. PubMed DOI

Ottmann C.; Weyand M.; Sassa T.; Inoue T.; Kato N.; Wittinghofer A.; Oecking C. A Structural Rationale for Selective Stabilization of Anti-tumor Interactions of 14-3-3 proteins by Cotylenin A. J. Mol. Biol. 2009, 386, 913–919. 10.1016/j.jmb.2009.01.005. PubMed DOI

Würtele M.; Jelich-Ottmann C.; Wittinghofer A.; Oecking C. Structural view of a fungal toxin acting on a 14-3-3 regulatory complex. EMBO J. 2003, 22, 987–994. 10.1093/emboj/cdg104. PubMed DOI PMC

Rose R.; Rose M.; Ottmann C. Identification and structural characterization of two 14-3-3 binding sites in the human peptidylarginine deiminase type VI. J. Struct. Biol. 2012, 180, 65–72. 10.1016/j.jsb.2012.05.010. PubMed DOI

Smidova A.; Alblova M.; Kalabova D.; Psenakova K.; Rosulek M.; Herman P.; Obsil T.; Obsilova V. 14-3-3 protein masks the nuclear localization sequence of caspase-2. FEBS J. 2018, 285, 4196–4213. 10.1111/febs.14670. PubMed DOI

Molzan M.; Weyand M.; Rose R.; Ottmann C. Structural insights of the MLF1/14-3-3 interaction. FEBS J. 2012, 279, 563–571. 10.1111/j.1742-4658.2011.08445.x. PubMed DOI

Kim Y.-W.; Grossmann T. N.; Verdine G. L. Synthesis of all-hydrocarbon stapled α-helical peptides by ring-closing olefin metathesis. Nat. Protoc. 2011, 6, 761–771. 10.1038/nprot.2011.324. PubMed DOI

Winn M. D.; Ballard C. C.; Cowtan K. D.; Dodson E. J.; Emsley P.; Evans P. R.; Keegan R. M.; Krissinel E. B.; Leslie A. G. W.; McCoy A.; McNicholas S. J.; Murshudov G. N.; Pannu N. S.; Potterton E. A.; Powell H. R.; Read R. J.; Vagin A.; Wilson K. S. Overview of the CCP 4 suite and current developments. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2011, 67, 235–242. 10.1107/S0907444910045749. PubMed DOI PMC

Battye T. G. G.; Kontogiannis L.; Johnson O.; Powell H. R.; Leslie A. G. W. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2011, 67, 271–281. 10.1107/S0907444910048675. PubMed DOI PMC

Evans P. Scaling and assessment of data quality. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2006, 62, 72–82. 10.1107/S0907444905036693. PubMed DOI

Evans P. R.; Murshudov G. N. How good are my data and what is the resolution?. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2013, 69, 1204–1214. 10.1107/S0907444913000061. PubMed DOI PMC

Lebedev A. A.; Vagin A. A.; Murshudov G. N. Model preparation in MOLREP and examples of model improvement using X-ray data. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2008, 64, 33–39. 10.1107/S0907444907049839. PubMed DOI PMC

Vagin A.; Teplyakov A. Molecular replacement with MOLREP. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 22–25. 10.1107/S0907444909042589. PubMed DOI

Adams P. D.; Afonine P. V.; Bunkóczi G.; Chen V. B.; Davis I. W.; Echols N.; Headd J. J.; Hung L.-W.; Kapral G. J.; Grosse-Kunstleve R. W.; McCoy A. J.; Moriarty N. W.; Oeffner R.; Read R. J.; Richardson D. C.; Richardson J. S.; Terwilliger T. C.; Zwart P. H. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 213–221. 10.1107/S0907444909052925. PubMed DOI PMC

Emsley P.; Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 2126–2132. 10.1107/S0907444904019158. PubMed DOI

Vecer J.; Herman P. Maximum Entropy Analysis of Analytically Simulated Complex Fluorescence Decays. J. Fluoresc. 2011, 21, 873–881. 10.1007/s10895-009-0589-1. PubMed DOI